Professor David Mant, Emeritus Professor of General Practice and Emeritus Fellow of Kellogg College, is made an OBE for services to medicine in the New Year's Honours List. Professor Mant is a member of the Oxford Biomedical Research Centre's Strategic Partnership Board. See full press release. ... READ MORE
News
The Alois community project – volunteering opportunity
The Cochrane Dementia and Cognitive Improvement Group, based at the JR Hospital, is running a volunteer recruitment campaign in conjunction with the development of a free online course “Making Sense of the Evidence in Dementia”, primarily aimed at caregivers and former caregivers of people with ... READ MORE
ARCII-study in Oxford – the human face of medical breakthrough
Last December, Kevin Jones, a 43-year-old businessman from Dorset was diagnosed with pancreatic cancer. It was advanced and inoperable. Today, as he prepares to celebrate Christmas with his son, Mr Jones is free from any detectable trace of the disease; the human face of a medical breakthrough so ... READ MORE
An aspirin a day helps to keep cancer at bay
Taking a low-dose aspirin every day will reduce your chances of dying from cancer, scientists say today, confirming the over-the-counter pill as the most extraordinary drug yet discovered. Daily aspirin has already been shown to cut the chances of heart attacks and stroke in people who are at ... READ MORE
Who’s the best surgeon for unblocking your arteries?
A Daily Mail article (23.11.10) features the country's top heart doctors, as recommended by their peers. Two of the best doctors (Adrian Banning and Bernard Prendergast) come from Oxford, read more. ... READ MORE
New retinal implant technique is being trialled in Oxford
A new retinal implant technique is being trialled at the Oxford Eye Hospital in 2011 for the first time in the UK. Professor Robert MacLaren, Consultant Retinal Surgeon at the Oxford Eye Hospital, is leading a trial to look at new technology that aims to restore sight to blind patients. By ... READ MORE
Aspirin ‘can significantly reduce’ bowel cancer risk
Professor Peter Rothwell, of the John Radcliffe Hospital, Oxford, and Oxford University, describes the findings of a recent study, tipping the balance in favour of regular aspirin ... READ MORE
Research Services Masterclass on the Human Tissue Act
The Research Services Medical Sciences team has organised a training session/masterclass on the implications of the Human Tissue Act (2004) for research. Date: Thursday 18 November 3.30-5pm All places now filled Location: Meeting Room, Grey Institute for Radiation ... READ MORE
Clinical trials begin of new treatment for advanced Melanoma in the UK & USA
Researchers at Immunocore Limited today announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the England and USA. IMCgp100 is the first clinical candidate ... READ MORE
Ethicist joins specialist commissioning group
OxBRC Ethics Fellow, Dr Mark Sheehan has been appointed to the panel of the Advisory Group for National Specialised Services (AGNSS). This committee advises health Ministers on which services should be nationally commissioned and the centres that should provide them. About 60 highly specialised ... READ MORE
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 90
- Next Page »